Avalon Investment & Advisory Guardant Health, Inc. Transaction History
Avalon Investment & Advisory
- $3.56 Billion
- Q1 2023
A detailed history of Avalon Investment & Advisory transactions in Guardant Health, Inc. stock. As of the latest transaction made, Avalon Investment & Advisory holds 14,644 shares of GH stock, worth $920,228. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,644
Previous 17,139
14.56%
Holding current value
$920,228
Previous $466,000
26.39%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding GH
# of Institutions
416Shares Held
127MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$765 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$706 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$313 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$302 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$267 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $6.42B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...